Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of ascorbic acid with NAB-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy [Phase 1]
Phase 1 study evaluating BI 765883 dose in advanced pancreatic cancer, with or without chemotherapy; the trial is terminated with posted res…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) [Phase 2, Phase 3]
A study evaluating Navlimetostat (BMS-986504) with nab-paclitaxel and gemcitabine versus placebo with nab-paclitaxel and gemcitabine in untr…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
A Phase 3 clinical trial comparing quemliclustat plus chemotherapy versus placebo plus chemotherapy in metastatic pancreatic ductal adenocar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 trial of daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active-not-recruiting, indicat…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue [Phase 2, Phase 3]
Clinical trial update for Ponsegromab in adults with cachexia due to metastatic pancreatic ductal adenocarcinoma (phases 2 and 3) currently …
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial evaluating chemotherapy with or without INCB161734 in previously untreated KRAS G12D-mutated metastatic pancreatic ductal aden…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers [Phase 1]
A Phase I trial evaluating [177Lu]Lu-NNS309, a radiopharmaceutical, in multiple advanced cancers including pancreatic ductal adenocarcinoma,…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating nab-paclitaxel plus cisplatin and gemcitabine in untreated metastatic pancreatic ductal adenocarcinoma; results hav…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies [Phase 1]
Pfizer's Phase 1 trial of PF-08046037 alone or with sasanlimab in advanced cancers has been terminated.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]
This is a Phase 2 clinical trial assessing relacorilant with nab-paclitaxel and gemcitabine for metastatic pancreatic ductal adenocarcinoma.…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trials evaluating elironrasib and daraxonrasib as solo therapies and in combination for advanced KRAS G12C-mutant…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma [NA]
Clinical trial update indicates that a study of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for inoperable pancreatic duc…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial evaluating the combination of gemcitabine, erlotinib, and nab-paclitaxel in basal-like pancreatic …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study for AZD4360 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial of AZD4360 in adults with advanced solid tumors, including gastric cancer and gastroesophageal junction cancer, is …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for locally advanced pancreatic cancer that cannot be removed su…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors [Phase 1]
Phase 1 update on LY4066434, a pan-KRAS inhibitor, in KRAS-mutant solid tumors, including pancreatic ductal adenocarcinoma and non-small cel…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 2]
A Phase 2 clinical trial update on Nuzefatide Pevedotin (BT5528) for metastatic pancreatic ductal adenocarcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors [Phase 1, Phase 2]
Verastem is evaluating the KRAS G12D-mutated cancer drug VS-7375 in a Phase 1/2 study across several solid tumors, including pancreatic duct…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients [Phase 1, Phase 2]
Clinical trial update for TNG462 in combination therapy for pancreatic ductal adenocarcinoma and non-small cell lung cancer, currently recru…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Pancreatic Cancer Early Detection Consortium
The Pancreatic Cancer Early Detection Consortium trial is currently recruiting to study early detection of pancreatic cancer and related pan…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for patients with resectable or borderline resectab…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Pancreatic Cancer Screening in a Population at High Risk [NA]
A clinical trial update on pancreatic cancer screening in a high-risk population sponsored by Masaryk Memorial Cancer Institute; the study t…